Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Wieland Capital - Family Office
Family Office (single/multi)
Wieland Capital is a Family Office focusing on the acquisition and development of small- and medium-sized companies (SMEs). The firm invests in profitable medium-sized businesses, real estate, forestry, and various other asset classes, emphasizing sustainable and long-term value creation.
Overview and Management
Establishment Year
2004
Mission
We strongly believe in sustainable and long-term value creation through operational performance rather than financial engineering.
Values
Entrepreneurship, sustainability, long-term partnership, reliability.
Investment Roles
Direct Investor
Participant Demographics
Focus on succession scenarios with founders and management teams; supports care service beneficiaries and other stakeholders in portfolio businesses.
Generational Wealth Planning
We think that a diversified portfolio of companies is a foundation of successful asset management and a keystone to long-term wealth preservation.
Risk Tolerance
Moderate risk tolerance with a focus on stable and sustainable value creation.
References or Case Studies
Team Experience
Nearly 20 years of investment experience.
Notable Achievements
Successful investments in various sectors, including the sale of PhagoMed to BioNTech in 2021.
Project Track Record
Investments in companies like Peptido, REMEMBER, doorout.com, and many others across different industries.
Exit Strategies
Strategic sales, e.g., REMEMBER sold in 2021, PhagoMed sold to BioNTech in 2021.
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance History
info@wieland-capital.com
Phone Number
+49 89 41 61 933 0
Address
München Germany